These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10804319)

  • 1. [Terbinafine-induced persistent agueusia: first reported case].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Terbinafine-induced ageusia and hyposmia].
    Villota Hoyos R; González-Ruiz M
    Aten Primaria; 1999 Feb; 23(2):102-3. PubMed ID: 10081177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ageusia caused by terbinafine].
    Martínez Yélamos S; Ballabriga Planas J; Peres Serra J; Prat Rojo J
    Med Clin (Barc); 1995 Sep; 105(7):276. PubMed ID: 7475473
    [No Abstract]   [Full Text] [Related]  

  • 4. Terbinafine and taste loss.
    Veraldi S; Pontini P; Serini SL
    G Ital Dermatol Venereol; 2016 Jun; 151(3):308-9. PubMed ID: 27176083
    [No Abstract]   [Full Text] [Related]  

  • 5. [On fungus and taste].
    Backhaus E
    Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2368. PubMed ID: 23367556
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia associated with oral terbinafine.
    Grunwald MH
    Int J Dermatol; 1998 Aug; 37(8):634. PubMed ID: 9732018
    [No Abstract]   [Full Text] [Related]  

  • 8. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis.
    Dominicus R; Weidner C; Tate H; Kroon HA
    Br J Dermatol; 2012 Jun; 166(6):1360-2. PubMed ID: 22136723
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious adverse events reporting on systemic terbinafine: a Danish register-based study.
    Bangsgaard N; Saunte DM; Folkenberg M; Zachariae C
    Acta Derm Venereol; 2011 May; 91(3):358-9. PubMed ID: 21290086
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature.
    Beltraminelli HS; Lerch M; Arnold A; Bircher AJ; Haeusermann P
    Br J Dermatol; 2005 Apr; 152(4):780-3. PubMed ID: 15840114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of taste and terbinafine.
    Juhlin L
    Lancet; 1992 Jun; 339(8807):1483. PubMed ID: 1351157
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK; Lynch LE; Kogan N; Cooper EA
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hepatitis related to the ingestion of terbinafine].
    Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
    Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
    [No Abstract]   [Full Text] [Related]  

  • 18. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 19. Objective assessment of terbinafine-induced taste loss.
    Doty RL; Haxel BR
    Laryngoscope; 2005 Nov; 115(11):2035-7. PubMed ID: 16319619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.